<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180603039967N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-04</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of basil extract in insomnia .</public_title>
      <acronym></acronym>
      <scientific_title>The comparison of the efficacy of hydroalcoholic extract of ocimum basilicum and placebo in treatment of insomnia in depressed patients who are referred to psychiatry clinic of Hafez hospital in Shiraz (a randomized double blind clinical trial)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34495</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to equalize the number of the members of the groups, the restricted randomization and random allocation rule will be used . 
in random allocation rule  , classically 2 different color balls in equal numbers will be throwed in a bag and the order of removal of the balls will be recorded
. participants will get in two groups by the same order (Of course this process  will be done by randomization saftwares  and the code 1 and code 2 will
 be recorded instead of  colors.)
 .Beacause the patients visit the doctor in a few days of a week and also a few number of the patients will fill the including criteria ,
 the sampling needs several days to complete . 
so sampling would be done via simple intermittent method and it starts with adding the first patient and finishes when the number of patients achives the study goal .
60 not transparent sealed envelopes with same external appearance will be prepared in two 30 people groups as indicator of the participants .
Each envelope consists of questonnaires with the code1 or 2.
 Based on the order of random allocation achived in previous step, the envelopes are  placed in a box in the office. 
The researcher who is visiting the patients, gives them the envelopes based on the order .After recieving the envelopes,
 the patients will open the envelope and fill the questionnaire in a seperate room.
 The drug and the placebo are in seperate boxes with same appearance.
 Each patient recieves a box based on the code of the questionnaires ( code1 or code2).
 It should be noted that none of the researchers  of this study are involved in random allocation and aware of the boxes that patients recieve.
 All the steps, including random allocation, seeing the code of the questionnaire, and giving
 the drug to the patients is done by a coworker out of the study , Blinding description: After the patient was visited by the physician, a not transparent and sealed  envelope containing the questionnaire and the code 1 or 2 will be given to the patient .
 The patient will open the envelope in a separate room and will answer the questionnaires. Queationnaires have a specific code and it would be seen by a coworker  in that room and a box with the same code which may contain drug or placebo would be delivered to the patient. None of the researchers are aware of the code of the envelopes and  questionnaires. As a result reserchers are not aware of the source of the medications the patients are recieving.
 Also the patients can not differentite between placebo and the drug due to same appearance and taste.
  It should be noted that none of the researchers  of this study would be involved in random allocation and aware of the boxes that patients recieve. All the steps, including random allocation, seeing the code of the questionnaire, and giving the drug box to the patients is done by a coworker out of the study .</study_design>
      <phase>2-3</phase>
      <hc_freetext>Major deprassion + Insomnia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Ocimum basilicum  will be dried and hydroalcoholic extract will be prepared. Capsules will be filled with hydroalcoholic extract powder . The patients will recieve 1100 mg of extract 1 hour before sleep each night. The patients will recieve the capsules for 4 weeks. The extract is made in school of pharmacy of SUMS. Intervention 2: Control group: Placebo with same appearance will be prepared for control group. Capsules will be filled with starch .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All deidentified individual participant data collected in this study will be available for other researchers

When:
1 year after publishing the results of study

To whom:
The data will be available for all researchers

Conditions:
The data are available for all researchers who want to improve the human life quality

Where to obtain:
Dr Mohammadreza Nazari
00989107001457
mohammad1992nn@gmail.com

How to obtain:
By a phone call or leaving a messeage  and after informing my colleagues I will send you the scanned files

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Nazari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Alavi dormitory, No 2 Alley, Mollasadra Ave, Namazi Square</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7193613565</zip>
        <telephone>+98 71 3212 2464</telephone>
        <email>culture@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Hamdollah Mosavat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Iranian traditional medicine group, Shiraz college of medicine , Zand Blvd,</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7134845794</zip>
        <telephone>+98 71 3234 5145</telephone>
        <email>hamdi_88114@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patients betwwen 18 to 65 years old suffering from major deppresion
Getting at least the score 12 out of 28 of the insomnia severity index questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Taking any sedative medication in last month
Sufferng from significant medical diseases like cardiopulmonary failure, cancer, vascular disease, rheumatologic diseases, history of seizure, thyroid disease, ...
Taking anticoagulant or antiplatelet medications like warfarin, aspirin ,...
Opioid and alcohol addiction
Pregnancy and lactation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G47.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Insomnia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Ocimum basilicum  will be dried and hydroalcoholic extract will be prepared. Capsules will be filled with hydroalcoholic extract powder . The patients will recieve 1100 mg of extract 1 hour before sleep each night. The patients will recieve the capsules for 4 weeks. The extract is made in school of pharmacy of SUMS.</i_keyword>
      <i_keyword>Control group: Placebo with same appearance will be prepared for control group. Capsules will be filled with starch .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Beck depression inventory score /Insomnia Severity Index score (ISI) / Pittsburgh Sleep Quality Index score(PSQI). Timepoint: Filling the questionnaires before starting the intervention and 4 week after taking drug. Method of measurement: Beck depression inventory  /Insomnia Severity Index (ISI) / Pittsburgh Sleep Quality Index (PSQI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-08-19</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Shiraz Univercity of Medical Sciences central building، Zand Blvd Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
